Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Neuro-Oncology
•
Medical Oncology
•
ASCO 2025
What are your top takeaways in Neuro Oncology from ASCO 2025?
Related Questions
Under what circumstances would you consider irradiation for brain metastases with active or recent bleeding?
How would you approach treatment for a glioblastoma from a radiation standpoint that was initially thought to be a metastases and therefore treated with multiple courses of SRS over the past few years?
Would you consider adding gabapentin off label for use in the treatment of glioblastoma at this time?
What are your top takeaways from ASCO GU 2025?
What are the best radiation therapy options for a young adult with 3 brain metastases from myeloid sarcoma that hasn’t responded well to intrathecal therapy?
What are your top takeaways in Gyn Cancers from ASCO 2025?
Are you offering Lutathera for multiple recurrent meningiomas?
What experience do you have with paralysis or myasthenia like symptoms developing on Temozolomide?
In what circumstances would you consider use of IDH inhibitors in high-grade astrocytomas?
What are your top takeaways in Head & Neck Cancers from ASCO 2025?
